Skip to content

Using AI, continuous glucose monitors, and an equity approach, diabetes care could be saving many more lives, Stanford Medicine researchers say.

Using AI, continuous glucose monitors, and an equity approach, diabetes care could be saving many more lives, Stanford Medicine researchers say.

Improvements in treatment technology are helping physicians deliver individualized care to their Type 1 diabetes patients.

Improvements in treatment technology are helping physicians deliver individualized care to their Type 1 diabetes patients.

Published on

Preksha Bhagchandani, a Stanford Medicine MD-PhD student, was inspired to become a diabetes researcher and doctor by her own diagnosis.

Preksha Bhagchandani, a Stanford Medicine MD-PhD student, was inspired to become a diabetes researcher and doctor by her own diagnosis.

Results from a multi-center clinical trial show that a drug lowers the risk of kidney failure by a third in people with Type 2 diabetes and kidney disease.

Results from a multi-center clinical trial show that a drug lowers the risk of kidney failure by a third in people with Type 2 diabetes and kidney disease.